Remedium Lifecare Ltd - Stock Valuation and Financial Performance

BSE: 539561 | NSE: | Trading | Small Cap

Remedium Lifecare Share Price

108.50 -1.65 -1.50%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Remedium Lifecare

Overall Rating
Bole Toh

1. Quality

2. Valuation

Somewhat Undervalued

3. Price Trend

Remedium Lifecare stock performance -

mw4me loader
P/E Ratio (SA):
14.43
Market Cap:
1,093.7 Cr.
52-wk low:
24
52-wk high:
179.7

Is Remedium Lifecare Ltd an attractive stock to invest in?

1. Is Remedium Lifecare Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Remedium Lifecare Ltd is a below average quality company.

2. Is Remedium Lifecare Ltd undervalued or overvalued?

The key valuation ratios of Remedium Lifecare Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Remedium Lifecare Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Remedium Lifecare Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Remedium Lifecare:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Remedium Lifecare Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % 1%19.8%0.5%0.1%0.5%0.2%8.1%5.4%12.8%67.5%-
Value Creation
Index
-0.90.4-1.0-1.0-1.0-1.0-0.4-0.6-0.13.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 2.62.13.91.30.40.22.9905055102,709
Sales YoY Gr.--19.4%85.4%-66.2%-73.7%-54.3%1,706.3%3,015.2%460.7%1%-
Adj EPS 00.1000000.10.10.57.5
YoY Gr.-NA-100%NANANANA66.7%120%336.4%-
BVPS (₹) 0.20.30.30.30.30.30.30.40.519
Adj Net
Profit
00.600000.30.51.14.976
Cash Flow from Ops. -0.10.1-1.40.1-0.2-0.1-0.2-10.211.320.5-
Debt/CF from Ops. -2.71.2000-1.1-1.8-100-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales 79.5%329.2%460.9%1%
Adj EPS NANA152%336.4%
BVPS17.6%28%46.1%110.2%
Share Price - 187.8% 323.4% 332.4%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
1.121.40.30.10.50.28.413.324.563.4149.7
Op. Profit
Mgn %
0-7.8-7.6-7.40.2-43.213.40.80.41.42.4
Net Profit
Mgn %
127.70.20.33.93.99.40.50.212.8
Debt to
Equity
0.1000000.12.700-
Working Cap
Days
7098674151,0503,2436,3663518294485435
Cash Conv.
Cycle
4696633258012,1892,0451101017275

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 149.70%

Sales growth is growing at healthy rate in last 3 years 460.85%

Net Profit is growing at healthy rate in last 3 years 151.98%

Sales growth is good in last 4 quarters at 363.83%

No data to display

Latest Financials - Remedium Lifecare Ltd.

Standalone Consolidated
TTM EPS (₹) 7.5 -
TTM Sales (₹ Cr.) 2,709 -
BVPS (₹.) 9 -
Reserves (₹ Cr.) 81 -
P/BV 12.03 -
PE 14.43 -
From the Market
52 Week Low / High (₹) 23.96 / 179.66
All Time Low / High (₹) 0.41 / 179.66
Market Cap (₹ Cr.) 1,094
Equity (₹ Cr.) 10.1
Face Value (₹) 1
Industry PE 76.7

Management X-Ray of Remedium Lifecare:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Remedium Lifecare

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales324100390505510
Operating Expenses 324100389503503
Manufacturing Costs0011000022
Material Costs223000288498494
Employee Cost 0000000001
Other Costs 0000001137
Operating Profit 0000000127
Operating Profit Margin (%) 0.0%-7.9%-7.6%-7.4%0.2%-43.2%13.4%0.8%0.4%1.4%
Other Income 0100000001
Interest 0000000000
Depreciation 0000000000
Exceptional Items 0000000000
Profit Before Tax 0100000127
Tax 0000000002
Profit After Tax 0100000015
PAT Margin (%) 1.0%27.7%0.3%0.3%3.9%5.0%9.6%0.5%0.2%1.1%
Adjusted EPS (₹)0.00.10.00.00.00.00.00.10.10.5
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 23333334510
Share Capital 4444444444
Reserves -1-1-1-1-1-10017
Minority Interest0000000000
Debt00000001100
Long Term Debt00000001100
Short Term Debt0000000000
Trade Payables42100002412584
Others Liabilities 00000000941,060
Total Liabilities 7653344392241,154

Fixed Assets

Gross Block2200000000
Accumulated Depreciation1100000000
Net Fixed Assets1100000000
CWIP 0000000000
Investments 0000000000
Inventories21100013847
Trade Receivables22322012464172
Cash Equivalents 00000111122
Others Assets11111211174953
Total Assets 7653344392241,154

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 00-10000-101121
PBT 0100000127
Adjustment 0000000000
Changes in Working Capital -0-1-10-00-1-111015
Tax Paid 000000000-2
Cash Flow From Investing Activity 0010010000
Capex 0010000000
Net Investments 0000000000
Others 0000010000
Cash Flow From Financing Activity 000000010-110
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 000000010-110
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow 00000100120
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)1.0621.40.360.110.450.268.6213.3324.5170.92
ROCE (%)1.524.60.660.140.550.6211.167.3918.16102.54
Asset Turnover Ratio0.390.320.760.340.110.050.744.213.850.74
PAT to CFO Conversion(x)NAN0-INFNANNANNANNAN-INF114.2
Working Capital Days
Receivable Days2043832246882,1892,487103513285
Inventory Days265280100004705783133
Payable Days000001,42681505477

Remedium Lifecare Ltd Stock News

Remedium Lifecare Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Remedium Lifecare on 28-Mar-2024 16:01 is ₹108.5.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Remedium Lifecare stood at ₹1,093.7.
The latest P/E ratio of Remedium Lifecare as of 28-Mar-2024 16:01 is 14.43.
The latest P/B ratio of Remedium Lifecare as of 28-Mar-2024 16:01 is 12.03.
The 52-week high of Remedium Lifecare is ₹179.7 and the 52-week low is ₹23.96.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Remedium Lifecare is ₹2,709 ( Cr.) .

About Remedium Lifecare Ltd

Remedium Lifecare Ltd. (formerly known as Roxy Exports Limited) is a BSE listed company. The company has made a paradigm shift by entering into the manufacturing of intermediates and APIs and be reckoned as a leading contract manufacturer and as a brand owner of advanced intermediates & APIs. The strategic acquisition of the state-of-the-art manufacturing facilities in Hyderabad, was a timely move to forward integrate and diversify into the pharma & healthcare arena. A massive facility with 2 dedicated manufacturing blocks is now ready for large scale manufacture.

The company is engaged into the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Amino isophthalic Acid, Tellurium (IV) Oxide, Grignard Reagent, lodine, Selenium Metal Powder, Trimethyl Sulfoxonium lodide (TMSI).

Business area of the company

The company is pharmaceutical company aligned across two business verticals viz. Products and Services. Its Products business comprises manufacture and sale of APIs and Intermediates to innovator and generic pharmaceutical players in both Domestic and International markets including the regulated markets.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.